tradingkey.logo

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD

ReutersMar 4, 2025 1:18 PM

- PepGen Inc PEPG.O:

  • PEPGEN ANNOUNCES UPDATE TO PHASE 2 CONNECT2-EDO51 STUDY IN PATIENTS WITH DMD

  • PEPGEN INC - TO PAUSE PHASE 2 CONNECT2-EDO51 STUDY IN DMD PATIENTS

  • PEPGEN INC - DATA FROM 10 MG/KG COHORT EXPECTED IN Q3 2025

  • PEPGEN INC: WILL FOCUS EFFORTS ON ONGOING CONNECT1-EDO51 STUDY OF PGN-EDO51 IN DMD

  • PEPGEN INC - NO NEW SAFETY ISSUES OBSERVED IN PGN-EDO51 PROGRAM

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI